You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ARR

Showing 1 - 25 of 339
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aldosterone Renin Ratio Test to Increase Case-detection of

Not yet recruiting
  • Primary Aldosteronism
  • Blood test for ARR
  • Cleveland, Ohio
    The Cleveland Clinic Foundation
Feb 24, 2023

Type A Aortic Dissection, Ascending Aortic Dissection, Aortic Diseases Trial in Saint-Denis (Conservative Root- Sparing Aortic

Enrolling by invitation
  • Type A Aortic Dissection
  • +6 more
  • Conservative Root- Sparing Aortic Valve Resuspension with or without Hemiarch Repair
  • +3 more
  • Saint-Denis, France
    Francesco Nappi
Jun 23, 2023

Aortic Root and Long-term Outcomes For Acute Type A Aortic

Completed
  • Type A Aortic Dissection
  • Bentall
  • +2 more
  • (no location specified)
Apr 25, 2022

Stroke Trial in Shatin (Rehabilitation Training System)

Recruiting
  • Stroke
  • Rehabilitation Training System
  • Shatin, Hong Kong
    Department of Biomedical Engineering, The Chinese University of
Nov 17, 2020

An Intervention to Increase Genetic Testing in Families Who May

Recruiting
  • BRCA1 Mutation
  • +21 more
  • Intervention Arm At-risk Relative/ARR Contacts
  • +5 more
  • Basking Ridge, New Jersey
  • +7 more
Nov 22, 2022

Primary Aldosteronism In Hypertensive Patients in China

Completed
  • Hyperaldosteronism; Primary
  • Hypertension Secondary
  • Aldosterone/renin ratio (ARR) testing
  • Confirmatory tests
  • Chongqing, Chongqing, China
    The First Affiliated Hospital of Chongqing Medical University
Oct 22, 2020

Multiple Sclerosis Trial (Frexalimab, Teriflunomide, Placebo infusion)

Not yet recruiting
  • Multiple Sclerosis
  • (no location specified)
Nov 15, 2023

First-line DMD Treatments for Multiple Sclerosis (CLAD CROSS)

Active, not recruiting
  • Multiple Sclerosis
  • Alexandroupolis, Greece
  • +52 more
Sep 28, 2022

MRA and ARB Treatment in Screening of Primary Aldosteronism

Completed
  • Primary Aldosteronism Due to Aldosterone Producing Adenoma
  • canrenone 50-100 mg orally once a day
  • olmesartan 10-20 mg orally once a day
  • Padova, Italy
    Department of Medicine - DIMED, University of Padova, Italy
Dec 2, 2019

Multiple Sclerosis (MS) Trial in Dallas (Alemtuzumab)

Completed
Has Results
  • Multiple Sclerosis (MS)
  • Dallas, Texas
  • +1 more
Jan 24, 2022

Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial

Not yet recruiting
  • Neuromyelitis Optica Spectrum Disorder
  • +2 more
    • (no location specified)
    Jul 21, 2023

    Gynecologic Cancer, Ovary Cancer, Pancreatic Cancer Trial in Houston (Free genetic testing and counseling group, IGNITE-TX

    Not yet recruiting
    • Gynecologic Cancer
    • +8 more
    • Free genetic testing and counseling group
    • +2 more
    • Houston, Texas
      MD Anderson Cancer Center
    Jan 11, 2023

    Primary Aldosteronism in Hypertension With 24-hour URinary

    Recruiting
    • Hypertension
    • +2 more
      • Cambridge, United Kingdom
        Vascular Research Clinic, Adenbrooke's Centre of Clinical Invest
      Sep 15, 2023

      Relapsing Multiple Sclerosis (RMS) Trial in United States (Ublituximab, Teriflunomide, Oral Placebo)

      Completed
      Has Results
      • Relapsing Multiple Sclerosis (RMS)
      • Ublituximab
      • +3 more
      • Phoenix, Arizona
      • +12 more
      Nov 11, 2021

      Relapsing Multiple Sclerosis (RMS) Trial in United States (Ublituximab, Teriflunomide, Oral Placebo)

      Completed
      Has Results
      • Relapsing Multiple Sclerosis (RMS)
      • Ublituximab
      • +3 more
      • Carlsbad, California
      • +13 more
      Nov 5, 2021

      Neuromyelitis Optica Trial in Hangzhou (CD19 CAR-T cells injection)

      Recruiting
      • Neuromyelitis Optica
      • CD19 CAR-T cells injection
      • Hangzhou, Zhejiang, China
        The first affiliated hospital of medical college of zhejiang uni
      Apr 12, 2023

      Multiple Sclerosis (MS) Trial in Worldwide (Fingolimod, Ofatumumab, Siponimod)

      Recruiting
      • Multiple Sclerosis (MS)
      • Little Rock, Arkansas
      • +55 more
      Jan 13, 2023

      Diagnosing Variable Primary Aldosteronism.

      Recruiting
      • Primary Aldosteronism
      • High Blood Pressure
        • London, United Kingdom
          Queen Mary University of London
        Mar 14, 2023

        SAAE on Vascular Endothelial Function in PA Patients

        Recruiting
        • Primary Aldosteronism
        • Nanchang, China
          The Second Affiliated Hospital of Nanchang University
        Dec 12, 2022

        Inebilizumab and Rituximab in Neuromyelitis Optica Spectrum

        Not yet recruiting
        • Neuromyelitis Optica Spectrum Disorders
        • (no location specified)
        Sep 29, 2023

        Diroximel Fumarate Real-world Experience in Canada and Israel

        Recruiting
        • Relapsing Forms of MS
        • Diroximel Fumarate
        • Haifa, Israel
        • +5 more
        Jan 31, 2023

        Primary Aldosteronism LC-MS/MS-specific Cutoffs

        Recruiting
        • Primary Aldosteronism
        • Captopril Challenge Test
        • Chongqing, Chongqing, China
        • +1 more
        Jul 24, 2023

        Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, NMO Spectrum Disorder Trial in Tianjin (Daratumumab, Placebo)

        Recruiting
        • Neuromyelitis Optica
        • +2 more
        • Tianjin, Tianjin, China
          Tianjin Medical University General Hospital
        Oct 19, 2022

        Immune Cells and Meningeal Lymphatic Drainage in Demyelinating

        Recruiting
        • Multiple Sclerosis
        • +2 more
        • Tianjin, Tianjin, China
          Tianjin Medical University General Hospital
        Oct 19, 2022

        Exploring Clinical Study Experiences of People With Depression

        Not yet recruiting
        • Depression
          • San Francisco, California
            Power Life Sciences
          Jun 30, 2023